chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt. received HPV last pt was talking, acting good stood up and walked behind mom and loss of conscious layed pt down on floor, took vital signs were in N/L range pt. didn't want nothing to eat or drink still not acting good, couldn't remember where she was called EMS to take to ER.
neck pain Narrative: from non-facility medical record ER intake: 76-year-old male with past medical history CKD, hypertension, CAD with MI, type 2 diabetes presents to the emergency department via EMS with reported syncope. Patient amnesic to events and unable to contribute to HPI. Per EMS patient was found on the bathroom floor by his wife this morning. Patient denies preceding symptoms of dizziness, headache, chest pain, visual disturbances. He states he does not remember going to the bathroom this morning. In ED patient complaining of neck pain and presents with fever. He currently denies headache, chest pain, cough, shortness of breath, abdominal pain, nausea, vomiting or injury to extremities. Patient reports that he had COVID-19 in December 2020. He did receive the COVID-19 vaccine yesterday, states that he was at his baseline last night prior to going to bed and denies having fever or myalgias yesterday.
101.4 fever, soreness at injection site, joint pain, itching around injection site, redness at injection site, nausea, light headed. Soreness, swelling, redness continues 6 days after injection. Redness, swelling and itching is not getting better.
Vaccine exposure during pregnancy; This spontaneous prospective pregnancy report was received from a medical assistant, refers to a 21-year-old female patient. The patient's medical history, concurrent conditions and concomitant medications were unknown. The medical assistant reported the patient "had her titers drawn and was not immune to varicella" on an unspecified date. The medical assistant reported the patient had her last menstrual period on 31-MAR-2019 to 6-APR-2019. On 05-APR-2019 the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) (dose, frequency and route of administration unknown) lot # R026715, expiry date: 18-SEP-2020 for prophylaxis. The medical assistant reported the patient missed her next menstrual period and did a home pregnancy test, a few days ago and it was positive (exposure during pregnancy). The medical assistant reported the patient had a urine pregnancy test done in the office on 21-MAY-2019 which was positive. The medical assistant reported the patient had blood work drawn on 21-MAY-2019 for a " complete blood count (CBC), human chorionic gonadotropin (HCG) total, HCG with gestational table", but results are not yet available. The patient became pregnant with last menstrual period (LMP) of 31-MAR-2019 and estimated date of delivery (EDD) of 05-JAN-2020. The pregnancy outcome was outcome pending.
Bad pain in right jaw area when open mouth, chew, or sneeze a day after vaccine given; Pain in right pinky finger; Dull headache on right side; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC2588) via an unspecified route of administration in the right arm on 13Sep2021 at 17:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 14Sep2021 at 15:00, the patient experienced bad pain in right jaw area when open mouth, chew, or sneeze a day after vaccine was given. She also experienced pain in right pinky finger and dull headache on right side. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment with unspecified anti-inflammatory prescription medications. On 27Sep2021, the patient underwent nasal swab test and the result was negative. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the event bad pain in right jaw area when open mouth, chew, or sneeze a day after vaccine given, pain in right pinky finger and dull headache on right side was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a pharmacist refers to a patient of unknown age with no drug reactions or allergies and with no medical history reported. On 23-APR-2014, the patient was inadvertently administered a second dose of ZOSTAVAX, intramuscularly (dose, lot number unknown). No concomitant medications and laboratory tests were reported. It was not known when the first dose had been administered. There was no adverse effects reported. Additional information has been requested.
Extremely high blood pressure, severe headache, nausea, vomiting, blurred vision.
I had a left reverse shoulder replacement on 3/09/2022. I had my vaccination, then the next day I woke up and felt extreme pain and could not move my arm or fingers. The pain was worse than when I came home from my surgery. My pain was at a 10 rating. I went to my doctor and my pains medications were doubled and to use ice. This seemed to trigger and relapse my shoulder pain. It has subsided some and back to healing again without as much pain. I also had a fever for 5 days after the vaccination as well then after that I started vomiting.
Nausea, lightheaded, elevated BP. Went home and started having body aches, joint pain. Improved nausea.
Pt at vaccination table after receiving first dose Johnson and Johnson vaccine. Nurse states she left table to get the lot # and upon returning pt stiffened up, eyes rolled into back of head. 1425 staff assisted in lowering pt to the floor where he began to demonstrate convulsions lasting no more than 30 seconds. Nurses and EMS responded. Pupils dilated , skin pale and stated "am I okay? Hello." Nurse told pt what had happened. A&O and able to tolerate water. Pt states no past medical hx. BP 118/62, HR 62, O2 97% and POC 108.  Pt sat up, stated feeling nauseous and started to vomit. Pt assisted to stretcher at 1440. Pt educated on going to hospital for further evaluation. At this time pt is refusing transport and wants to wait.
This spontaneous prospective pregnancy report as received from a registered nurse, concerning an 18 year old female. Patient's past drug history was unknown. On 08-SEP-2012, the patient was vaccinated with the first dose of GARDASIL, a second dose of GARDASIL 12-APR-2012 (also reported on 12-APR-2011) and a third dose of GARDASIL on 29-MAY-2012 (three doses: lot # 671006/1291AA, expired on 12-APR-2014; dose and route not reported). Concomitant medications were unknown. As of 29-MAY-2012, the patient was 6 months pregnant. Relevant laboratory data was unknown. As of 2-MAY-2012, the patient remained six months pregnant. Follow-up information has been received which reported the patient with no concurrent medical conditions and no previous pregnancies was vaccinated with a first dose of GARDASIL (lot #, dose and route not provided) on 02-SEP-2008, a second dose GARDASIL (lot #, dose and route not provided) on 12-APR-2011 and a GARDASIL on 29-MAY-2012 (lot # 671006/1291AA) (dose and route not provided). Concomitant therapies included prenatal vitamins daily (manufacturer unknown), iron and calcium. The patient became pregnant with EDD of 18-JUL-2012. The date of last menstrual period was 10-OCT-2011. On 01-MAR-2012 an ultrasound was performed to confirm gestation which showed viable intrauterine gestation, transverse lie. On an unknown date, the patient experienced anemia. At the time of reporting, the patient's pregnancy outcome was unknown. At the time of the report, the outcome of anemia was unknown. All telephone attempts to obtain follow-up information have been unsuccessful. Additional information is not expected.
Had 2 tonic clonic ( grand mal) seizures. Had to be rushed to emergency.
patient became violent for nine days; patient became hysterical for nine days; This spontaneous case was reported by a consumer and describes the occurrence of AGGRESSION (patient became violent for nine days) and CONVERSION DISORDER (patient became hysterical for nine days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced AGGRESSION (patient became violent for nine days) and CONVERSION DISORDER (patient became hysterical for nine days). At the time of the report, AGGRESSION (patient became violent for nine days) and CONVERSION DISORDER (patient became hysterical for nine days) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient stated that she had similar reaction in the past when she received iodine in a medical substance. Concomitant medications were not reported. Treatment information in response to events was not provided.
Fever, Rash, INJECTION SITE PAIN, FATIGUE, LYMPHADENOPATHY Narrative:
Rash from the injection site to all the way down to the wrist; This case was reported by a pharmacist via call center representative and described the occurrence of rash in a 102-year-old female patient who received Herpes zoster (Shingrix) (batch number HY4GT, expiry date 30th September 2021) for prophylaxis.   On 8th August 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. In August 2019, 3 days after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was recovered/resolved.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and experienced a rash from the injection site to all the way down to the wrist. It appeared 3 days after vaccination and it resolved about 4 days later. The reporter consented to follow up. No further details were provided.
pt had 4 inch rash near injection site, nausea, and dizziness, she said she was not sick enough to seek medical care, she is to check in with me again if she does not get better or if anything gets worse, also told she can seek outside medical attention if needed
This spontaneous report was received from a medical assistant and refers to a 12 month old patient of unknown gender. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not reported. On 29-AUG-2017, the patient was vaccinated with improperly stored VARIVAX injection, (lot # N007930 with expiration date on 08-MAR-2018, dose, anatomical location and route) for prophylaxis, reconstituted with properly stored sterile diluent (manufacturer unknown) (lot# N013282 with expiration date 23-AUG-2019). The administered vaccine experienced a temperature excursion of 6 degree Fahrenheit to 14 degree Fahrenheit for 18 hours. There was no previous temperature excursion and the call was not because of a data logger. No adverse effects were reported. This is one of the several reports received from the same reporter.; Sender's Comments:  US-009507513-1709USA001401: US-009507513-1710USA008701: US-009507513-1709USA000870:
Patient reports redness and itching around the injection site for one week following injection, denies pain or purulent discharge, denies swelling.
Early Monday afternoon, I had chills and had to bundle up in blankets. Temperature was 95.7 taken twice with two digital thermometers. I felt dizzy and at ties disoriented. I stayed bundled in there blankets for the day. Later that evening my temperature shot up to 103.6. After a few hours my temperature dropped to 96.7. The alternating high and low temperature continued until Wednesday November 22. My temperature now (November 24) is 97.8. I am listless, my eyes feel swollen and there is pressure on my sinuses. I feel run own.
Headache-occipital neuralgia  for more than one month.; This is a spontaneous report from a contactable consumer (patient). This 65 year old female consumer reported for herself that:   A 65-years-old female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE;Solution for injection ; Batch/Lot Number: El1283), dose 2 via an unspecified route of administration, administered in Arm Left on 11Feb2021 08:30  as SINGLE DOSE for covid-19 immunisation.The patient medical history was not reported. The patient's concomitant medications were not reported.The patient experienced headache-occipital neuralgia  for more than one month.on 25Jan2021 outcome of the events was recovering
I had a minor reaction to the injection at the time of both doses.  Less than 5 minutes after receiving the shot, I experienced the physical effects of a panic attack despite my relatively calm attitude about the vaccine: I felt very tense, my heartbeat sped up, and I was slightly short of breath.  As well as I can recall, I've never had a panic attack before in my life.  The reaction lasted a few minutes longer the first time than the second time, with both durations in the 10-15 minute range.  Neither caused any problems, and I did not have any noticeable subsequent effects beyond arm soreness.  However, almost 2 months later, this past Wednesday night, I opted to kiss someone for the first time with both of our mouths open.  Not instantly, but again, less than 5 minutes after the kiss, I had the physical sensation of a panic attack.  I had not been nervous at all about the kiss or the person, and I was not expecting any form of discomfort to follow.  But the effect felt exactly the same as the reaction I'd had to the Moderna vaccine, and it lasted roughly the same amount of time.
5 min. after vaccine felt really bad center back pain . Loss consciousness  and was transferred to ER by ambulance.
1st dose in 2019, 2nd on 09Mar2023; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 52-year-old male patient who received HAB (Twinrix) (batch number 2KE55, expiry date 22-SEP-2023) for prophylaxis.   Previously administered products included Twinrix (1st dose received in 2019).   On 09-MAR-2023, the patient received the 2nd dose of Twinrix. On 09-MAR-2023, an unknown time after receiving Twinrix, the patient experienced drug dose administration interval too long (Verbatim: 1st dose in 2019, 2nd on 09Mar2023). The outcome of the drug dose administration interval too long was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 13-MAR-2023 A pharmacist reported that a patient received the 1st dose of Twinrix in 2019 and a late 2nd dose on 09 March 2023. The reporter consented to follow up via email. On 09-MAR-2023, the patient received the 2nd dose of Twinrix, which led to lengthening of vaccination schedule.
Muscle Pain throughout the body; Fatigue; Sensitive to touch; Flu Like Symptoms; This case was reported by a pharmacist via call center representative and described the occurrence of influenza-like symptoms in a 58-year-old male patient who received Herpes zoster (Shingrix) (batch number H549S, expiry date 1st October 2021) for prophylaxis.   On 19th July 2019, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. In July 2019, less than 2 weeks after receiving Shingrix, the patient experienced influenza-like symptoms, muscle pain, fatigue and touch sensitivity increased. On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved and the outcome of the muscle pain and fatigue were recovering/resolving and the outcome of the touch sensitivity increased was unknown.   It was unknown if the reporter considered the influenza-like symptoms, muscle pain, fatigue and touch sensitivity increased to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix vaccine in the left arm and experienced flu like symptoms which lasted for 2 days. The patient was also experiencing muscle pain throughout the body, fatigue and sensitivity to touch. The muscle pain and fatigue had decreased. No further details were provided.
This spontaneous report as received from a registered nurse refers to an approximately 28 year old patient. On 12-SEP-2013 the patient (who was approximately 28 year old then)was vaccinated with the first dose of GARDASIL (lot number, expiry date, route and dose unknown). No adverse event reported. No other information to the report. Additional information is not expected.
Severe joint pain & stiffness, decreased range of motion, travels throughout different joints - knees, ankles, wrists, elbows, & fingers.  12/1/09 OB/GYN Consult records received, service dates 11/03/09. Assessment: Pregnancy, normal, multigravida. Patient presents with complaint of depression.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Pertinent medical history was unspecified by reporter. On 02-OCT-2014 the patient was inadvertently vaccinated with an expired dose of PNEUMOVAX 23 (dose, route of administration and lot number was unknown, expiry date: 11-JUN-2014). Concomitant medications were unspecified by reporter. No adverse effects reported. The outcome of the events was unknown. No further information has been requested.
This case was reported by a pharmacist via call center representative and described the occurrence of raised rash in a 63-year-old male patient who received SHINGRIX (batch number 7FY22, expiry date 25th June 2020). On 12th May 2018 13:17, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. In May 2018, less than a week after receiving SHINGRIX, the patient experienced raised rash, skin scaly and injection site warmth. In May 2018, the outcome of the injection site warmth was recovered/resolved. On an unknown date, the outcome of the raised rash and skin scaly were recovering/resolving. It was unknown if the reporter considered the raised rash, skin scaly and injection site warmth to be related to SHINGRIX. Additional details were provided as follows: This case was reported by the patient's wife to the pharmacist. The age at vaccination was not reported. The patient's wife reported on Tuesday, 15th May 2018 that on Saturday the patient received SHINGRIX vaccine on the left arm. The patient experienced a circular raised rash around the site. It was scaly and warm to the touch. At the reporting time, the area was no longer warm but the rash was still there. The pharmacist's call was transferred to medical information for additional information and for recommendation if the patient should have the 2nd shot.
The pt experienced a mild case of chicken pox. The reporter also noted that her son experienced a similar reaction.
This case was reported by a healthcare professional and described the occurrence of lightheadedness in a 34-year-old male subject who was vaccinated with ENGERIX B (GlaxoSmithKline), BOOSTRIX. On 21 March 2011 the subject received 5th dose of ENGERIX B (20 mcg, unknown route, right arm) and 1st dose of BOOSTRIX (details unknown), and experienced extra dose administered (ENGERIX B). On 21 March 2011, less than one day after vaccination with BOOSTRIX and ENGERIX B, the subject experienced lightheadedness. At the time of reporting the lightheadedness was resolved. The healthcare professional considered the lightheadedness was possibly related to vaccination with ENGERIX B and BOOSTRIX.
I have primary Raynaud's syndrome. NO auto immune issues. This only affects me in the winter. This is the first summer where I am having Raynaud's symptoms AND two new symptoms for me: 1. I have tingling in both my hands and feet and 2. My right fingers/hand turn blue out of no where. This has never happened to me before.
pt was given Baby dose not Peds dose of Pfizer. Mom was contacted and CDC was also contacted. Gave information about repeat ASAP. Parents would like to talk about it giving correct dose vs waiting for omicon
expired dose administered; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a patient who received Men B NVS (Bexsero) (batch number unknown, expiry date 30th September 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 9th January 2023, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On 9th January 2023, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt date: 09-JAN-2023 Reporter comment: a pharmacist reported that a patient was given an expired dose of Bexsero on 9th January 2023. The Bexsero expired on 30th September 2022.  No symptoms reported. Did not consent to follow-up. The HCP declined to provide report details and declined consent for follow-up. HCP states she would report on her end. Additional Supportive Information: The patient received an expired dose of Bexsero vaccine which led to expired vaccine used.
This spontaneous report as received from a registered nurse refers to a 6 months old patient. The patient's concurrent conditions, medical history and drug allergies were not reported. On 07-NOV-2016, the patient was vaccinated with improperly stored ROTATEQ, oral, (dose not reported) from lot # M006112 with expiry date: 16-NOV-2016 for prophylaxis. Concomitant medications were not reported. The vaccine was exposed to a temperature of 34.5 Fahrenheit for 100 minutes. Data logger was involved. There were no previous excursions. No adverse events were reported. Product quality complaint was not involved. This is one of the several reports received from the same reporter. Additional information is not expected as all correspondence has been received. Sender's Comments: US-009507513-1610USA008140: US-009507513-1610USA014705:
This spontaneous report as received from a physician refers to a patient of unknown age. The physician reported that the patient had been vaccinated with 2 doses of VARIVAX (Merck) (lot# unknown, strength, dosage and route unknown). On an unknown date the patient had negative antibody titers to varicella. Lab test included antibody titers. The outcome of the event was unkonwn. The causality of the event and VARIVAX (Merck) was unknown. Additional information has been requested.